Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
3 clinical trials · Condition
◉ Watch Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (NCT07000383) | University Medical Center Ho Chi Minh City (UMC) | 2025-06-15 |
| Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome (NCT06681012) | Devintec Sagl | 2024-10-22 |
| Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type (NCT05923892) | Otsuka Beijing Research Institute | 2023-08-02 |
Track Irritable Bowel Syndrome of Diarrhea Type (IBS-D) automatically
Every clearance here is in the API, with alerts when new ones post.